Özet:

Objective: Our clinic is to evaluate the non-sick and general survival results of patients who apply with the diagnosis of Non-cellular Lung Cancer (MRI) and who receive neoadjuvan and adjuvan treatment with this diagnosis and to determine the prognostic effect of the patient and tumor characteristics in the early stage of MRI. Instruments and Methods: By retrospective scaning the files of patients with ADHD, who appeared to our clinic between January 2005 and June 2010, the patient and tumor characteristics, non-sickness and general survival data, the predictive effect of the patient and tumor characteristics were studied. The Neoadjuvan group consisted of 47 patients, and the primary opera group consisted of 135 patients. Adjuvan chemotherapy has provided significant benefits in patients of Phase III in terms of both non-sick survival (p=0,001) and general survival (p<0,001). In the Neoadjuvan treatment group, the response rate was 25.5%, and 23.4 percent of patients could have been operated. Patients in stage III who received neoadjuvan treatment did not find a reduction in survival compared to the adjuvan group in the same stage; the treatment resulted in a significant increase in survival in patients who were able to retard the nodal stage and operate (43,9±5,8 months 20,2±1,7 months). The result: Adjuvan chemotherapy survival has only significantly increased in patients of stage III. Neoadjuvan therapy has provided the survival advantage if the mediastinal nodal stage is retarded.Tumor diameter,vascular invasion and breast wall invasion have been identified as important tumor characteristics in terms of unhealthy and general survival.

Anahtar Kelimeler: